EP1543036A4 - Protein for diagnosing diabetic retinopathy - Google Patents
Protein for diagnosing diabetic retinopathyInfo
- Publication number
- EP1543036A4 EP1543036A4 EP03708726A EP03708726A EP1543036A4 EP 1543036 A4 EP1543036 A4 EP 1543036A4 EP 03708726 A EP03708726 A EP 03708726A EP 03708726 A EP03708726 A EP 03708726A EP 1543036 A4 EP1543036 A4 EP 1543036A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- protein
- diabetic retinopathy
- diagnosing diabetic
- diagnosing
- retinopathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/16—Ophthalmology
- G01N2800/164—Retinal disorders, e.g. retinopathy
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR2002041771 | 2002-07-16 | ||
KR20020041771 | 2002-07-16 | ||
PCT/KR2003/000544 WO2004007554A1 (en) | 2002-07-16 | 2003-03-20 | Protein for diagnosing diabetic retinopathy |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1543036A1 EP1543036A1 (en) | 2005-06-22 |
EP1543036A4 true EP1543036A4 (en) | 2006-07-05 |
Family
ID=30113191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03708726A Withdrawn EP1543036A4 (en) | 2002-07-16 | 2003-03-20 | Protein for diagnosing diabetic retinopathy |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060240484A1 (en) |
EP (1) | EP1543036A4 (en) |
JP (1) | JP2006506606A (en) |
KR (1) | KR100528664B1 (en) |
CN (1) | CN1675246A (en) |
AU (1) | AU2003212700A1 (en) |
CA (1) | CA2492980A1 (en) |
WO (1) | WO2004007554A1 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2414399B (en) | 2004-05-28 | 2008-12-31 | Cilag Ag Int | Injection device |
GB2414401B (en) | 2004-05-28 | 2009-06-17 | Cilag Ag Int | Injection device |
GB2414400B (en) | 2004-05-28 | 2009-01-14 | Cilag Ag Int | Injection device |
GB2414402B (en) | 2004-05-28 | 2009-04-22 | Cilag Ag Int | Injection device |
GB2414775B (en) | 2004-05-28 | 2008-05-21 | Cilag Ag Int | Releasable coupling and injection device |
GB2414409B (en) | 2004-05-28 | 2009-11-18 | Cilag Ag Int | Injection device |
GB2414406B (en) | 2004-05-28 | 2009-03-18 | Cilag Ag Int | Injection device |
GB2414403B (en) | 2004-05-28 | 2009-01-07 | Cilag Ag Int | Injection device |
JP2006528361A (en) * | 2004-07-06 | 2006-12-14 | クンイル ファーマシューティカル カンパニー リミテッド | Retinal vascular disease diagnostic composition containing aldolase and diagnostic method thereof |
US7733025B2 (en) | 2004-12-01 | 2010-06-08 | Lg Electronics Inc. | Plasma display panel |
GB2427826B (en) | 2005-04-06 | 2010-08-25 | Cilag Ag Int | Injection device comprising a locking mechanism associated with integrally formed biasing means |
GB2424838B (en) | 2005-04-06 | 2011-02-23 | Cilag Ag Int | Injection device (adaptable drive) |
GB2424836B (en) | 2005-04-06 | 2010-09-22 | Cilag Ag Int | Injection device (bayonet cap removal) |
GB2424835B (en) | 2005-04-06 | 2010-06-09 | Cilag Ag Int | Injection device (modified trigger) |
GB2425062B (en) | 2005-04-06 | 2010-07-21 | Cilag Ag Int | Injection device |
ATE452670T1 (en) | 2005-08-30 | 2010-01-15 | Cilag Gmbh Int | NEEDLE DEVICE FOR A PREFILLED SYRINGE |
US20110098656A1 (en) | 2005-09-27 | 2011-04-28 | Burnell Rosie L | Auto-injection device with needle protecting cap having outer and inner sleeves |
AU2007209977A1 (en) * | 2006-01-27 | 2007-08-09 | George Mason Intellectual Properties, Inc. | Ocular fluid markers |
GB2438590B (en) | 2006-06-01 | 2011-02-09 | Cilag Gmbh Int | Injection device |
GB2438593B (en) | 2006-06-01 | 2011-03-30 | Cilag Gmbh Int | Injection device (cap removal feature) |
KR100866579B1 (en) * | 2006-06-01 | 2008-11-11 | 아이진 주식회사 | Kit for diagnosing diabetic retinopathy |
GB2438591B (en) | 2006-06-01 | 2011-07-13 | Cilag Gmbh Int | Injection device |
KR100961926B1 (en) * | 2007-08-30 | 2010-06-10 | 서울대학교산학협력단 | Biomarker composition for detecting diabetic retinopathy and diagnostic kit therefor |
GB2461086B (en) | 2008-06-19 | 2012-12-05 | Cilag Gmbh Int | Injection device |
GB2461084B (en) | 2008-06-19 | 2012-09-26 | Cilag Gmbh Int | Fluid transfer assembly |
GB2461085B (en) | 2008-06-19 | 2012-08-29 | Cilag Gmbh Int | Injection device |
GB2461087B (en) | 2008-06-19 | 2012-09-26 | Cilag Gmbh Int | Injection device |
GB2461089B (en) | 2008-06-19 | 2012-09-19 | Cilag Gmbh Int | Injection device |
GB2515038A (en) | 2013-06-11 | 2014-12-17 | Cilag Gmbh Int | Injection device |
GB2515032A (en) | 2013-06-11 | 2014-12-17 | Cilag Gmbh Int | Guide for an injection device |
GB2517896B (en) | 2013-06-11 | 2015-07-08 | Cilag Gmbh Int | Injection device |
GB2515039B (en) | 2013-06-11 | 2015-05-27 | Cilag Gmbh Int | Injection Device |
CN105837666A (en) * | 2015-12-30 | 2016-08-10 | 田梗 | Protein for diagnosis of diabetic retinopathy |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001021658A1 (en) * | 1999-09-24 | 2001-03-29 | Human Genome Sciences, Inc. | 32 human secreted proteins |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9805913D0 (en) * | 1998-03-19 | 1998-05-13 | Kings College University Of Lo | Diagnosis of ms |
-
2003
- 2003-03-20 JP JP2004521236A patent/JP2006506606A/en not_active Abandoned
- 2003-03-20 CA CA002492980A patent/CA2492980A1/en not_active Abandoned
- 2003-03-20 CN CNA03819533XA patent/CN1675246A/en active Pending
- 2003-03-20 WO PCT/KR2003/000544 patent/WO2004007554A1/en active Application Filing
- 2003-03-20 EP EP03708726A patent/EP1543036A4/en not_active Withdrawn
- 2003-03-20 US US10/521,675 patent/US20060240484A1/en not_active Abandoned
- 2003-03-20 AU AU2003212700A patent/AU2003212700A1/en not_active Abandoned
- 2003-03-21 KR KR10-2003-0017815A patent/KR100528664B1/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001021658A1 (en) * | 1999-09-24 | 2001-03-29 | Human Genome Sciences, Inc. | 32 human secreted proteins |
Non-Patent Citations (5)
Title |
---|
EUN YOUNG LEE ET AL: "IMMUNOGLOBULIN A NEPHROPATHY IN PATIENTS WITH NON-INSULIN DEPENDENT DIABETES MELLITUS", JOURNAL OF KOREAN MEDICAL SCIENCE, KOREAN ACADEMY OF MEDICAL SCIENCE, SEOUL, KR, vol. 14, 1999, pages 582 - 585, XP008047555, ISSN: 1011-8934 * |
KAWAMURA S ET AL: "Nucleotide sequence of the gorilla immunoglobulin alpha 1 gene.", NUCLEIC ACIDS RESEARCH. 25 AUG 1989, vol. 17, no. 16, 25 August 1989 (1989-08-25), pages 6732, XP002382012, ISSN: 0305-1048 * |
NICOLOFF GEORGE ET AL: "Changes in the serum levels of anti-elastin antibodies are associated with the development of microvascular complications in children with Type 1 diabetes mellitus", CENTRAL-EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 26, no. 1, 2001, pages 17 - 23, XP002382011, ISSN: 1426-3912 * |
RODRIGUEZ-SEGADE S ET AL: "High serum IgA concentrations in patients with diabetes mellitus: agewise distribution and relation to chronic complications.", CLINICAL CHEMISTRY. JUL 1996, vol. 42, no. 7, July 1996 (1996-07-01), pages 1064 - 1067, XP002381324, ISSN: 0009-9147 * |
See also references of WO2004007554A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2006506606A (en) | 2006-02-23 |
US20060240484A1 (en) | 2006-10-26 |
EP1543036A1 (en) | 2005-06-22 |
KR100528664B1 (en) | 2005-11-15 |
AU2003212700A1 (en) | 2004-02-02 |
CA2492980A1 (en) | 2004-01-22 |
CN1675246A (en) | 2005-09-28 |
KR20040007237A (en) | 2004-01-24 |
WO2004007554A1 (en) | 2004-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1543036A4 (en) | Protein for diagnosing diabetic retinopathy | |
EP1693448A4 (en) | Double specific antibodies substituting for functional protein | |
GB2394052B (en) | Walkaway tomographic monitoring | |
EP1546985A4 (en) | Condition analysis | |
EP1532173A4 (en) | Protein analysis | |
AU2003294206A8 (en) | Methods for diagnosing htlv-i-mediated diseases | |
GB0201808D0 (en) | Protein | |
GB0208089D0 (en) | Protein | |
AU2003255823A1 (en) | Diagnostic test | |
AU2003223192A1 (en) | Proteins for helicobacter diagnosis | |
EP1587833A4 (en) | Epad, an oocyte specific protein | |
AU2002951543A0 (en) | Condition analysis | |
GB0204735D0 (en) | Protein | |
GB0202748D0 (en) | Protein | |
GB0219890D0 (en) | Diagnostic test | |
GB0207141D0 (en) | Modified protein | |
GB0216601D0 (en) | Modified protein | |
GB0203159D0 (en) | Protein | |
GB0205264D0 (en) | Protein | |
GB0203156D0 (en) | Protein | |
GB0203157D0 (en) | Protein | |
GB0203040D0 (en) | Protein | |
GB0203160D0 (en) | Protein | |
GB0203161D0 (en) | Protein | |
GB0203165D0 (en) | Protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050212 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/58 20060101ALI20060523BHEP Ipc: G01N 33/68 20060101AFI20060523BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060607 |
|
17Q | First examination report despatched |
Effective date: 20070112 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20071120 |